Caseware UK (AP4) 2024.0.164 2024.0.164 2023-12-312023-12-312025-05-07Management consultancy activities other than financial management2023-01-01true3false3trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 13547516 2023-01-01 2023-12-31 13547516 2021-08-04 2022-12-31 13547516 2023-12-31 13547516 2022-12-31 13547516 c:Director2 2023-01-01 2023-12-31 13547516 d:CurrentFinancialInstruments 2023-12-31 13547516 d:CurrentFinancialInstruments 2022-12-31 13547516 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 13547516 d:CurrentFinancialInstruments d:WithinOneYear 2022-12-31 13547516 d:ShareCapital 2023-12-31 13547516 d:ShareCapital 2022-12-31 13547516 d:RetainedEarningsAccumulatedLosses 2023-12-31 13547516 d:RetainedEarningsAccumulatedLosses 2022-12-31 13547516 c:OrdinaryShareClass1 2023-01-01 2023-12-31 13547516 c:OrdinaryShareClass1 2023-12-31 13547516 c:OrdinaryShareClass1 2022-12-31 13547516 c:FRS102 2023-01-01 2023-12-31 13547516 c:AuditExempt-NoAccountantsReport 2023-01-01 2023-12-31 13547516 c:FullAccounts 2023-01-01 2023-12-31 13547516 c:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 13547516 2 2023-01-01 2023-12-31 13547516 e:PoundSterling 2023-01-01 2023-12-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 13547516









XMEDIQ UK & IRELAND LIMITED







UNAUDITED

DIRECTORS' REPORT AND FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 DECEMBER 2023

 
XMEDIQ UK & IRELAND LIMITED
REGISTERED NUMBER: 13547516

BALANCE SHEET
AS AT 31 DECEMBER 2023

2023
2022
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
55
55

Cash at bank and in hand
 5 
257
200

  
312
255

Creditors: amounts falling due within one year
 6 
(8,456)
(5,171)

Net current liabilities
  
 
 
(8,144)
 
 
(4,916)

Total assets less current liabilities
  
(8,144)
(4,916)

  

Net liabilities
  
(8,144)
(4,916)


Capital and reserves
  

Called up share capital 
 7 
100
100

Profit and loss account
  
(8,244)
(5,016)

  
(8,144)
(4,916)


Page 1

 
XMEDIQ UK & IRELAND LIMITED
REGISTERED NUMBER: 13547516
    
BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2023

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




................................................
J Wedgbury
Director

Date: 7 May 2025

The notes on pages 3 to 5 form part of these financial statements.

Page 2

 
XMEDIQ UK & IRELAND LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

1.


General information

XMEDiQ UK & Ireland Limited (registered number: 13547516) is a private company, limited by shares, incorporated in the United Kingdom and registered in England and Wales. The company's registered office address is 101 New Cavendish Street, 1st Floor South, London, W1W 6XH.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Going concern

In assessing the ability of the company to operate as a going concern, management have evaluated current and forecasted operational results, and the solvency of the company. Given that the company is in a net deficit position, the shareholder has provided assurances to continue to provide adequate funds to meet its obligations, and not to demand repayment of any funds due to them, until the company is in a financial position to do so. As a result, the director considers it appropriate to prepare the financial statements on a going concern basis. 

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.5

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.6

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 3

 
XMEDIQ UK & IRELAND LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

3.


Employees




The average monthly number of employees, including directors, during the year was 3 (2022 - 3).


4.


Debtors

2023
2022
£
£


Other debtors
55
55

55
55



5.


Cash and cash equivalents

2023
2022
£
£

Cash at bank and in hand
257
200

257
200



6.


Creditors: Amounts falling due within one year

2023
2022
£
£

Trade creditors
330
330

Amounts owed to group undertakings
6,096
3,316

Amounts owed to related parties
600
600

Accruals and deferred income
1,430
925

8,456
5,171



7.


Share capital

2023
2022
£
£
Allotted, called up and fully paid



100 (2022 - 100) ordinary shares shares of £1.00 each
100
100


Page 4

 
XMEDIQ UK & IRELAND LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

8.


Controlling party

The ultimate parent company is XMED iQ International Limited, a company incorporated in England and Wales with a registered office at 101 New Cavendish Street, 1st Floor South, London, W1W 6XH.

 
Page 5